The British Journal of Psychiatry 136: 591-596 (1980)
© 1980 The Royal College of Psychiatrists
A pilot of plasma thioridazine and metabolites in chronically treated patients
AS Papadopoulos, TG Chand, JL Crammer and S Lader
Plasma concentrations of thioridazine, mesoridazine, sulphoridazine and
thioridazine ring sulphoxide have been measured individually by specific
gas-liquid chromatographic (GLC) methods, and collectively by a
radio-receptor assay, in 16 elderly in-patients during chronic treatment.
The sulphoridazine level was above 0.135 microgram/ml in 5 out of 6
symptomatically well-controlled patients, and below this level in 9 out of
10 who were poorly controlled. No such division was so clear for the other
substances measured. A new assay for the total dopamine receptor-blocking
activity of the plasma correlated highly at lower levels with the sum of
drug plus metabolites obtained by GLC, but exceeded the sum at higher
values. Both sulphoridazine and neuroleptic levels need further study.